Altered lipidomics and increased hepatic production of prothrombogenic factors, including fetuin-A in patients with fibrosing NASH, can be potential contributors to the link between NASH and cardiovascular diseases [55]. Here, AHSG is linked to metabolic dysfunction-associated steatohepatitis.